GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 717 filers reported holding GLAXOSMITHKLINE PLC in Q2 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $779,000 | -86.2% | 18,217 | -85.2% | 0.01% | -86.4% |
| Q3 2014 | $5,646,000 | -10.7% | 122,820 | +3.9% | 0.04% | -10.2% |
| Q2 2014 | $6,324,000 | -29.5% | 118,249 | -29.6% | 0.05% | -32.9% |
| Q1 2014 | $8,972,000 | -9.3% | 167,929 | -9.3% | 0.07% | -7.6% |
| Q4 2013 | $9,888,000 | +4.1% | 185,201 | -2.2% | 0.08% | -2.5% |
| Q3 2013 | $9,500,000 | +26.6% | 189,362 | +26.1% | 0.08% | +24.6% |
| Q2 2013 | $7,501,000 | – | 150,112 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |